Schizophrenia: A New Approach. II. Result of a Year's Research
Journal of Mental Science – January 01, 1954
Source: OpenAlex
Summary
A groundbreaking hypothesis suggests that a substance, termed M substance, could play a crucial role in schizophrenia. This theoretical compound shares biochemical similarities with mescaline and adrenaline, potentially explaining various schizophrenia-related illnesses more effectively than existing theories. A collaborative effort involving three authors has been dedicated to testing this hypothesis over the past year. Their findings may pave the way for innovative approaches in psychology and psychiatry, offering fresh insights into the complex relationship between diet, metabolism, and mental health.
Abstract
About one year ago, with the encouragement of the Editor-in-Chief, a short paper appeared in this Journal entitled “Schizophrenia; A New Approach” (18). In this paper it was noted that mescaline and adrenaline have a similar biochemical structure. It was suggested that one of the aetiological agents in schizophrenia might be a substance or substances lying between these two; with the psychological properties of mescaline but effective in concentrations nearer those of adrenaline. Dr. Harley Mason elaborated this suggestion from the biochemical standpoint. For convenience these hypothetical substances were called, collectively, M substance. If M substance occurred in the body, it would account for the group of illnesses usually referred to as schizophrenia better than any hypothesis so far advanced. It has been the good fortune of the co-authors of that first paper (J. R. S. and H. O.) to be able to join forces with the third author of this paper (A. H.) to test the hypothsis. It is with the efforts of the last year that this paper is concerned.